3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
112
Lymphoma
66
Lymphoma, Large B-Cell, Diffuse
50
Precursor Cell Lymphoblastic Leukemia-Lymphoma
31
Lymphoma, Non-Hodgkin
29
Lymphoma, Follicular
22
Burkitt Lymphoma
22
Multiple Myeloma
19
Leukemia
16
Hodgkin Disease
16
Neoplasms
14
Neoplasm Metastasis
13
Lymphoma, B-Cell
13
Lymphoma, Mantle-Cell
11
Lymphoma, Large-Cell, Anaplastic
11
Lymphoma, T-Cell
8
Lymphoma, B-Cell, Marginal Zone
8
Lymphoma, T-Cell, Peripheral
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Hematologic Neoplasms
5
Waldenstrom Macroglobulinemia
4
Recurrence
4
Lymphoma, Large-Cell, Immunoblastic
4
Lymphoma, AIDS-Related
4
Immunoblastic Lymphadenopathy
4
Prostate Cancer Metastatic
3
Primary Myelofibrosis
3
Polycythemia Vera
3
Plasmablastic Lymphoma
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Interventions
Dexamethasone
17
Melphalan
14
Bortezomib
10
Calcium Dobesilate
8
Filgrastim
6
Granulocyte Colony-Stimulating Factor
5
Cyclophosphamide
5
birtamimab
4
dexamethasone acetate
3
Whole-Body Irradiation
3
Thalidomide
3
Peripheral Blood Stem Cell Transplantation
3
Lenalidomide
3
fludarabine phosphate
2
daratumumab
2
Mycophenolic Acid
2
Etoposide
2
Doxycycline
2
Darbepoetin alfa
2
Cyclosporine
2
Busulfan
2
Blood Component Removal
2
pomalidomide
1
pegfilgrastim
1
ixazomib
1
isatuximab
1
ferrous sulfate
1
ferric gluconate
1
dexamethasone 21-phosphate
1
carfilzomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Immunoglobulin Light-chain Amyloidosis
×
Prednisone
×
Clear all
No trials found.